How the COVID crisis has affected the transport of radiopharmaceuticals

This pictorial view is an initiative of the Nuclear Medicine Europe Transport Experts Working Group

The nuclear medicine sector, like everyone else, has faced and is still facing huge challenges during the coronavirus pandemic. NMEU’s Transport Expert Group surveyed its members to find out how it has affected the transport of radioactive material, from shipment and safety to controls and audits.

Their responses shine a light on the crucial role of transporters as a link between the industry and the patient, including their experience dealing with customs and administrative procedures that are outside the scope of traditional medical practices.” 

Share this post